FindTrial
Sign In

Role of fluid restriction (2/3rd versus total required fluid) in management of hypoxic ischemic encephalopathy (a variant of neurologic disorder of newborn)

Role of fluid restriction in management of hypoxic ischemic encephalopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052430
Enrollment
318
Registered
2023-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE]

Interventions

Intervention1: Fluid restriction: 2/3rd of maintenance fluid in first 5 days of life. Control Intervention1: Normal fluid: Total required intravenous fluid will be given in first 5 days of life.

Sponsors

Burdwan Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All newborns with hypoxic ischemic encephalopathy presented during study period

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Composite outcome of death and impaired neurodevelopment (DQ 70%)Timepoint: At 6th month—

Secondary

MeasureTime frame
Adverse events during course of treatment (ROP, PDA, AKI etc)Timepoint: Till discharge;Biochemical parameters in course of treatment Timepoint: Till discharge;Days in ventilationTimepoint: Till discharge;Hospital stayTimepoint: till discharge—

Countries

India

Contacts

Public ContactKamirul Islam

Katwa SDH, Burdwan

kamirul.islam7@gmail.com08972360456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026